Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by MikeyHon Jan 15, 2021 1:01pm
111 Views
Post# 32306955

RE:LOL Mikey, Mikey

RE:LOL Mikey, MikeySigh. Dart you really are hard of thinking aren't you?

So, yes SONA can sell into the EU now. Along with hundreds of others with the same self-certification. Good news. But we have a company of a dozen people with no sales team, no products and zero experience. You say you don't need individual country approval but YOU DO to sell to large buyers like the government. For example have a look at for the situation for rapid antigen test validation in the UK: https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/protocol-for-evaluation-of-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens-lateral-flow-devices. It is identical in France, Germany, Spain etc etc. IT SAYS IT THERE IN BLACK AND WHITE:

"There are an increasingly large number of commercial lateral flow antigen devices available. It is not feasible to conduct large scale evaluations on all of them; current sample resources only allow a limited number of devices for full evaluation. There is therefore a need to shortlist this limited number from many candidates as quickly as possible"

Please explain to me a situation where ANY large company would choose SONA over an established player that has been validated by the government (ie, a proper validation)? SONA has failed to get approval in the US and Canada because its clinical trial was weak, and it's 'validation' in the US was in fact a bog standard LoD lab test. The test is the absolute dictionary definition of "average at best"

CE Marking is a good thing, but it means little for SONA. The share price has halved in 10 days for a reason. You say if they don't put up or shut up now they'll fall flat on their faces. Dude - they already have fallen, and fallen hard.

Anyway, it's time for lunch. Arguing with brainless morons on the internet is the ultimate waste of time.
<< Previous
Bullboard Posts
Next >>